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ABSTRACT 
Starting wih a definition of immunity, this review describes general 
mechanisms by which immune system is modulated and details several 
immunotoxicological scfeening methods to assess the immumologic 
and host resistance alterations following chemical exposure. Among a 
variety of immuno toxic compounds known, only four representative 
mmpounds namely o-chloro benzylidine malononitrile (CS), 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), chloroquine, 1,fbis 
(2-chloroethyl) 1-nitrosourea (BCNU) have been chosen for an 
elaborate discussion. 
1. INTRODUCTION 
Th-e immune system is a surveillance mechanism to protect the host against 
disease-causing microorganisms such as bacteria, viruses and from parasites. The 
immune system is also esseniial to eliminate cancer cells in the body and any 
perturbation in the immune system cap lead to disease conditions called autoimmune 
diseases. These findings therefore suggest, how crucial it is to have an intact immune 
apparatus functioning in harmony with other systems of the body. 
In recent years, several xenobiotics were found to be toxic to the immune system. 
This meant that the xenobiotics had the capacity to suppress the body's defence against 
pathogenic microorganisms and cause increased susceptibility to cancer or autoimmune 
diseases. These serious repercussions made the toxicologists to realize the importance 
of including the immune system during the toxicity testing of various xenobiotics and 
led to the emergence of a new field of science called immunotoxicology. 
The definition of immunotoxicology is still open as it is still debatable as to which 
compounds should be called immunotoxic. Although a majority of the compounds 
tested are immunosuppressive, there are certain chemicals which enhance the activity 
of the immune system. Thus, immunotoxicology is a science that deals with the study 
of substances which alter the normal immune system. The use of the word 'alter' 
rather than 'toxic' is prefered because use of the word 'toxic' gives the impression 
that the compound is detrimental to the host by depleting the cells of the immune 
system. In contrast, a compound may destroy certain cells of the immune system such 
as the suppressor lymphocytes and thereby amplify the immune system which may 
be beneficial to the host. Thus, a compou~d may be 'toxic' but still be useful to the host. 
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In recent years, excellent literature reviews appeared, dealing with various aspects 
of immunofoxico1ogy.'" The present review briefly introduces the immune system, 
and deals in greater detail with the mechanisms of immunomodulation, 
immunotoxicological screening methods, immunotoxic compounds particularly 
referring to the studies on o-chlorobenzylidine malanonitrile (CS) and chloroquine 
which were carried out at the Defence Research & Development Establishment, 
Gwalior on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at McMaster University, 
Hamilton, Canada and on 1,3-bis(2-chloro-ethy1)l-nitrosourea (BCNU) carried out at 
the University of Kentucky, Lexington, KY, USA. 
2. IMMUNE SYSTEM 
The immune system can be broadly divided into nonspecific and specific immunity. 
2.1 Nonspecific Immunity 
There are several elements in the immune system which can protect in geneial 
against invasion by any foreign organisms or cells, collectively constituting the 
nonspecific defence mechanism. This system includes external skin which provides a 
passive barrier to the penetration of pathogens and cells such as blood monocytes 
and neutrophils or tissue macrophages which can phagocytose and digest a majority 
of the invading organisms. In addition, there are natural killer (NK) cells and 
lymphokine activated killer (LAK) cells which can eliminate a variety of parasitized 
cells and cancer cells. The phagocytes are also helped by a variety of humoral or 
circulating factors belonging to the nonspecific immune system such as lysozyme, 
C-reactive protein, properdin, complement, etc. 
2.2 Specific .Immunity 
The immune system also consists of specialized cells called lymphocytes which 
can specifically recognize and selectively eliminate the pathogens or foreign antigens. 
This component of the immune response is known for its exquisite specificity and for 
displaying a long-term memory of earlier exposure to the specific foreign antigen. 
Specific immunity can be divided into two components - humoral and cellular. 
Humoral immunity is provided by proteins called antibodies which circulate in the 
body. Antibodies are secreted by plasma ceHs which originate from lymphocytes called 
B cells. Humoral immunity defends primarily against infectious agents when they are 
not inside the host celb. Cellular immunity, in contrast, is effective against organisms 
which grow inside the cells and also against cancer cells. It is mediated by lymphocytes 
called T cells, since they need the thymus for maturatian. Functionally, at least 3 
main types of Tcells can be described - T helper cells which provide help in the form 
of various factors called lymphokines. These T cells can interact with other T cells or 
B cells and help them to differentiate and grow. The second type of Tcells are called 
cytotoxic Tlymphocytes (CTL). These cells can recognize cells bearing foreign antigens 
and they can lyse such cells. The-CTL are believed to play important role in protection 
against viral infections and against cancer. They are also the cause of major frustration 
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for transplantation immunologists since the hosts CTL recognize the foreign antigens , 
present on the transplanted grafts and cause their rejection. The third type of 
lymphocyte is called Tsuppressor cell (Ts). These lymphocytes help to down-regulate 
the ongoing immune response thereby making sure that the immune response tnggered 
by an antigen comes back to the original resting state. Recently yet another subset 
of T cell called contrasuppressor cell which down-regulates the Ts activity has been 
described. 
Morphologically all lymphocytes look alike. However, they differ in several of 
their surface properties, receptors and functions. The B cells have distinct surface 
antigens called Lyb while T cells hake Lyt antigens. The B cells also carry class I1 
major histocompatibility (MHC) antigens called la antigens (which these antigens) 
are generally absent on T cells. B cells recognize an antigen through its surface 
immunoglobulin or antibody molecule which serves as its receptor, while Tcells have 
a distinct receptor and the Tcell receptor can see a foreign antigen only in association 
with the MHC molecules. Thus, the Thelper cells generally recognize a foreign antigen 
in association with class I1 MHC molecules while the CIL respond to a foreign antigen 
in association with class T MHC molecule. There are a number of antigenic 
determinants on T cells closely associated with the T cell receptor functions. These 
antigens are essential for the recognition and activation of the T cells. T helper cells I 
have one such antigen called L3T4 while the CTL carry an antigenic determinant 
called Lyt2. The Ts cells carry I-J epitopes which are encoded by a locus called I-J. 
I-J has been defined as a locus mapped in the murine MHC which encodes serological 
markers found primarily on the surface of Ts and soluble suppressor factors (TsF). 
The I-J epitopes are known to play a major role in the functioning of Ts. 
3. GENERAL MECHANISMS OF IMMUNOTOXICITY 
Some of the possible mtchanisms by which xenobiotics can modulate the immune 
response is shown in Table I. The toxicity of a compound may depend on several 
Table 1. General Mechanisms of Immunotoxidty 
Direct bffects 
1 Cytotoxic to lymphoid organs such as bone marrow, thymus, lymph nodes and spleen. 
2 Cytotoxic to stem cells, T cells, B cells, macrophages or other circulating cells. 
I 
3 Effect on the antigen recognition, phagocytosis, processing and presentation. 
4 ~ l t e r a t i o n ~  in the T and B cell receptor functions. 
5 Effect on the production, release or action of mediators such as lymphokines, interleukins, interferrons, etc. 
6 Effect on immunoregulatory circuits such as on helper Tcells, suppressor Tcells or contrasuppressor T 
cells etc. 
Indirect Effects 
1 Mediated through the hormones which influence the immune response such as thyroid hormones, 
corticosterone and gonadotropins, thymic hormones etc. 
2 Mediated through nutritional deficiency, e.g. proteins, vitamins, minerals such as zinc etc. 
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factors. All species of animals may not respond to a particular xenobiotic in the same 
manner. Thus, genetic factors may influence the outcome of immunotoxicity. Secondly, 
the route of administration of the xenobiotic may be an important factor determining 
the immunotoxicity. Other factors include the amount and the duration of exposure. 
The concentrations in experimental animals of the compound to be screened should 
be close to simulate natural exposure in humans so that the extrapolation of the data 
from experimental animals to man is better appreciated. Lastly, a compound may not 
be directly cytotoxic to the cells of the immune.system but can modulate indirectly 
its function and therefore ceqain xenobiotics may be immunosuppressive at low doses 
unaccompanied by clinical signs of the disease. 
4. METHODS FOR SCREENING THE IMMUNE RESPONSE 
Testing a chemical for immunotoxicity has been found to be much more difficult 
than testing its toxicity on other systems. The reason is that a single or a few tests 
cannot reveal whether the immune system is intact or not, especially since the immune 
system consists of a network of milions of interacting'lymphocytes. A number of 
assays utilized in the Immunology Program at the National Institute of Environmental 
Health Sciences, U.S.A., to assess the immunologic and host resistance alterations 
following chemical exposure7 are listed in Table 2. 
It should be noted that most of these assays are direct without dealing with the 
complex cellular interactions invdlved in the immune system. Some of these tests may 
be extremely useful to assess whether a chemical has an overaIl immunotoxic effect. 
However, more research needs to be carried out to evaluateat the cellular and 
molecular level, the exact mechanism by which the chemicals alter _the immune 
response. Thus, tests need to be standardized to evaluate whether a xedobiotic affects 
the individual functrons of cells such as Th, CIZ, Ts or B cells. ~ u r t h e r b b ,  if it 
does affect, whefher it is due to its direct action on cells or through indireGNaotion-such 
as its action to inhibit the synthesis or release of lyrnphokines, like the interleukins. - 
Any immunologica! alterations brought about in one cell population can affect 
several other lymphwytes with varied functions. For example, a suppressed T helper 
cell response b n  lead to diminished CTL activity or B cell function. Suppression of 
T suppressor cells may, in-ontrast, lead to enhanced CTL activity and antibody 
production by B cells-a siwation which can be beneficial or deleterious to the host. 
For example, it may be beneficial to deplete T suppressor cells spe;cific to M. leprae 
in diseases like lepromatous leprosy, thereby permitting the effector T cells ta' act 
against the pathogen and control the infection. Hawever, depletion of T suppressor 
cells regulating the B cells specific to self antigens, can lead to developmqnt of 
autoimmune diseases. Also, in organ or tissue transplant recipients, it may be ben~ficial 
t,q spare the T suppressor cells while selectively depleting the effector T cells which 
dektroy the graft. 
?%us, the tests employed to screen chemicals for immunotoxicity may not only 
-lead to useful informiation on the potential risk of the exposed individuals tq 
susceptibility to &fecti?ns, cancer and autoimmune diseases, but if the chemicals are 
relatively nontoxic tp other systems' they may constitute important 
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immuno-modulating agents which can be used particularly in. the transplant program. 
Studies in this direction, may be regarded to  come under the subdiscipline of 
immunopharmacology. 
Table 2. Assays for m n g  Immuhe Alterations 
Parameter Procedure performed 
- -- 
Pathotoxicology Hematology profile (hemaglobin,red Mood cellcount, 
white blood cell count, differential) 
Liver chemistries (SGPT, triglycerides, cholestrol) 
Serum proteins (albumin, globulin, AIG, total proteins) 
Weights (body, spleen, thymus, liver, kidney, heart, lung, 
brain) 
Histology (liver, thymus, lung, kidney, spleen) 
Host resistance 
Delayed hypersensitivity 
Lymphocyte proliferation 
Humoral immunity 
Macrophage function 
Bone marrow colony. 
forming units 
Tumor assays (tumor cell challenge TD,, and 
radiometric tumor mass) 
Listeria monocytogens LD,,,, 
challenge 
Endotoxin hypersensitivity LD,,, 
Expulsion of Trichinella spirals 
Radiometricassay with Tcell-dependent antigen 
One-way mixedleukocyte culture 
Mitogens (PHA, Con A, LPS) 
Immunoglobulin levels (IgG, IgM, IgA) 
Antibody response to T-dependent and T-independent 
antigens 
Resident peritoneal cell numbers and nonspecific esterase 
staining 
Phagocytosis of "Cr-SRBC 
LySosomal enzymes (5'-nucleotidase, &id phosphatase, 
leucine amino peptidase) 
Cytostasis of tumor target cells 
Cytolysisof tumor target cells 
RES clearance using 125 I-trioleion 
- C N - S  (multipotent, hematopoietic stem cells) 
CFU-GM (granulocyte/macrophage progenitor) 
CFU-E (erythrocytes progenitor) 
Cellularity 
59 Iron incorporation in bone marrow 
. 5. IMMUNOTOXIC COMPOUNQS 
Table 3 summarizes various chemicals/xenobiotics, which have been known to 
alter the immune response and are therefore immunotoxic. 
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It should be noted that although a majority of the compounds listed in Table 3 
are immunosuppressive, there are a few compounds which are known to enhance the 
I 
Table 3. Immunotoxic compounds 
, 
Environmental contaminants - such as insecticides, pesticides, herbicides and heavy metals. Specifically 
halogenated biphenyls (PCB, PBB), TCDD, vinyl chloride, hexachlorobenzene. 
Pesticides - DDT, parathion, Lindane, Methylnitrophos, Hepatochlor, carbarnine, paraquat, chlorophos, 
etc. 
, 
Dusts + silica, carbon. 
Heavy metals - lead, cadmium, mercury, selenium, arsenicals, cobalt, nickel, silica, chromium, platinum 
1 
Addictive substanqs - alcohol, heroin, cigarette smoke etc. 
1 
Food additives - pyrogallol, vanillin, tartrazine, carrageenan, sacchatin, etc. I 
immune- response. For example, not all metals are immunosuppressive. Selenium 
enhances the immune response by increasing the number of antibody-forming ~ells ."~ 
'similarly, although some investigators have shown that hexachlorobenzene (HCB) 
suppresses humoral immune response, Vos 10 et al. found that HCB in fact stimulated 
the humoral immune response in the rat, enhanced the mitogenic responseiveness of 
the spleen cells and did not alter cell-mediated immunity. In addition, Levamisol, an 
antihelminthic drug has been found to enhance the immune response.'' 
5.1 Immunotoxicity of o-chlorobenzylidenemalailonitrile (CS) 
0-chlorobenzylidenemalanonitrile (CS) is one of the most comfnonly employed 
sensory irritants used in the control of riots.12 CS is an alkylating agent and many 
alkylating agents have been reported to be immunosuppressive due to their action on 
nucleic acids. However, CS differs from other alkylating agents in that it does not 
interact with nucleic acids in biological systems. Investigation of effect of CS on the 
immune system revealed that CS when used in sublethal doses in mice caused a 
decrease in the weight and cellularity of the thymus, suppressed the antibody response 
to thymus dependent and independent antigens and suppressed the DTH response to 
Sheep Red Blood Cells. It was also found that the effect of CS in lower doses was 
mediated directly on the lymphoid cells since the nutritional status and corticosterone 
levels were not altered significantly in CS-treated m i ~ e ' ~ , ' ~ .  
5.2 Immunotoxicity of TCDD 
TCDD is one of the most potent tollic chemicals known. It is found as an impurity 
during the production of 2,4,5-trichlorophenoxyacteic acid (2,4,5-T), used as a 
defoliant. Several studies suggested that TCDD is immunosuppressive lv6. 
TCDD has been shown to bind to a cytoplasmic protein, the synthesis of which 
is regulated at a locus called l5 'Ah, This binding results both in the induction of mixed 
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function oxidase enzvme activities and ,some of the toxic effects1' of TCDD. Inbred 
mouse strains can be divided into 'responsive' strains such as C57~L./6(Ah~/Ah~) 
where there is marked induction of the enzymes such as aryl hydrocarbon hydroxylase 
(Ahh) and 'nonresponsive' strains such as DBN2 (Ahd/Ahd) in which there i? low or 
no induction of the AHH. The genetically determined variation in susceptibility to 
the effects of TCDD is not linked to the H-2 locus since it has been shown that certain 
H-2d (Balblc) and H-2k (CBAIJ) strains are susceptible while others are more resistant 
to toxicity causedI6 by TCDD. 
We found that low d ~ s e s  of TCDD (4 nglkg) suppressed the generation of 
allospecific cytotoxic nymphocytes (CTL) from 'susceptible' C57BLl6 mice but not 
from 'resistant' DBN2 mice1' To determine if TCDD acted directly on the 
'susceptible' lymphoid cells, the immune response of C57BLl6 DBN2 and DBN2 
C57BLl6 allogeneic radiation bone marrow chimeras was also measured. We found 
that the susceptibility to suppression in chimeric mice was determined by the Ah 
genotype of the host and not by the genotype of the grafted lymphomyeloid cells. 
Experiments demonstrated that suppression of CTL generation by TCDD was due 
to T suppressor cells. The frequency of CTL precursors was not affected by TCDD. 
These results suggested that the Ah locus may play an important role in the 
immunotoxicity of certain carcinogens and haloaromatic hydrocarbons. 
5.3 Immunomodulation by chloroguine 
Chloroquine is a 4-aminoquinoline derivative used extensively in the treatment 
and prophylaxis of malaria. It has also been used to treat autoimmune diseases. The 
use of chloroquine as an anti-inflammatory drug and its ability to stabilize the lysosomal 
membranes suggested that chloroquine may have some immunomodulating effect in 
vivo. We therefore undertook a systematic analysis of the in vivo and in vitro effects 
of chloroquine on surface receptors of human peripheral lymphocytes1s. Chloroquine 
was administered orally to twenty normal individuals. The total number of circulating 
lymphocytes or leucocytes in the blood did not change significantly after chloroquine 
administration. However, there was a significant fall in the percentage and number 
of lymphocytes with erythrocyte (E) and complement ((73) markers and an increase 
in the cells lacking both these markers. Lymphocytes treated with chloroquine in vitro 
failed to show any change in their expression of E or C'3receptors. The sera from 
the chloroquine-treated individuals also failed to demonstrate any factor inhibiting 
the E and EAC rosette formation. These findings suggested that chloroquine may 
indirectly affect in vitro the normal expression of these receptors on lymphocytes. 
It has been demonstrated that treatment of macrophages with chloroquine leads 
to decreased antigen catabolism and such macrophages cannot process the foreign 
antigen and present19 it to the T cells. 
5.4 Immunotoxicity of Nitrosoureas 
Nitrosoureas constitute one of the extensively used classes of anticancer agents. 
They have clinical application especially because they are active against a range of 
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solid tumors and lymphomas. The cytotoxicity of these compounds is due to their 
metabolites, chloroethyl diazohydroxide and isocyanate. 
We have been particularly interested in BCNU 1,3-bis(2-ohloroethyl 
1-nitrosourea), since this compound cures a high percentage (> 90 percent).of mice 
bearing syngeneic tumors and more interestingly 100 percent of the cured mice are 
resistant to fechallange with the same These finding suggested'to us that 
BCNU may act on the immune system, in addition to i p  tumoricidal property. We 
observed that tumor-bearing mice cannot generate cytotoxic T cells (CTL) due to the 
fact that these mice develop greater numbers of T suppressor cells (Ts) which 
down-regulate the .CTL, response .against the tumor. However following 
BCNU-treatment, these tumor-bearing micegenerate high levels of CTL activity and 
so Ts-cell activi$. This suggest that BCNU selectively acted on tumor-specific Ts 
thereby permitting the antitumor CTLs to destroy the tumor cells. In addition, we 
have also found that treatment of tumor cell-targets in vivo or in vitro with BCNU 
increased their susceptibility to lysis caused by macrophages but not by the CTL or 
natural killer cells, . n u s ,  nitrosoureas in addition to the tumoricidal activity, seem to 
act in a variety of ways leading to an overall enhanced anti-tumor i m m ~ n i t y . ~  
6. IMMUNOTOXICOLOGY IN DEFENCE SCIENCE 
~ l t h o u ~ h  imtnunotoxicology is relatively a new field, a considerable amount of 
data accumulated during the past few years on immunotoxicity of certain xenobiotics. 
The majority of the research thus far carried out has been on environmental 
contaminants. Thus, ~onsiderable work is required to study the immunotoxicity of 
food additives, commonly used drugs, smoking and industrial solvents, pollutants and 
gases. From the Defence point of view there are several chemicals and some bacterial 
and fungal toxins which may be potential chemical warfares age?ts. E*urthermore, 
*ere are seireral chemicals used in the Defence industry to which the Defence indust~.al 
workers may be constantly exposed. These chemicals following low level exposure to 
humans;,and animals may cause i ~ u n o l o g i c a l  alteration's. Immunotoxi stvdies.on 
such chemic'als are essential to understand the potential risks of such exposure on the 
hosts defense mechanism. 
It is possible that v m e  of the toxic compounds may be antigenic, thereby evoking 
an antibody response in vivo. Alternatively, some may act as haptens and it is possible 
to couple these t9 larger protein molecules for use in vivo to produce ptibodies. If 
these antibodies can bind to the determinant on the parent molecul'e which is 
responsible for causing the toxicity, then it can lead to the biological inactivation of 
the parent molecule and thereby prevent the toxicity. This may constitute an 
immunological antidote-approach to neutralize the toxicity of certain compounds. 
Thus, passive administration of the antibotiies may be enough io firevent the toxic 
effects of the specific compound and this approach may be useful in biological or 
chemical warfare to protect against the toxicity of known chemicals or- toxins used. 
The antibodies can also be used to protect industrial workers against the toxic effects 
of known chemicals or gases during an accidental exposure. 
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Although this approach seems simple, we like to cautidn that practically it will 
involve elaborate and time consaming research first to identify the site of the parent 
molecule responsible for causing toxicity, to chemically link the niolecule with a large 
protein molecule which should be immunogenic but not toxic and then screen various 
antibodies raised, for their capacity to prevent the toxicity of the compound. 
7. CONCLUSION 
The field of immunotoxicology is new and is in the early stages of rapid 
development. Although several assays have been described to screen the immune 
*system, these do not cover the entire immune system which is very complex involving 
the interaction of lymphocytes and accessory cells at the cellular and molecular level. 
In addition to determining whether a chemical is immunotoxic or not, by including 
the immune system during routine toxicity studies; attempts must also be made to 
conduct basic research to address at the cellular and molecular level to the mechanism 
of immunomodulatory action of various xenobiotics. Screening the chemicals for 
immunotoxicity is not only useful to predict the susceptibility of the host to infections, 
cancerind autoimmune diseases, but may also be useful in the pharmaceutical industry 
to evaluate new compounds for the treatment of transplant recipients, cancers, 
autoimmune disorders and immunodeficiency diseases. 
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